skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Structural analysis and unique molecular recognition properties of a Bauhinia forficata lectin that inhibits cancer cell growth

Authors:
 [1];  [2];  [3];  [2];  [2];  [3];  [1]
  1. Macromolecular Crystallography Laboratory, Center for Cancer Research, National Cancer Institute, Frederick MD USA
  2. Chemical Biology Laboratory, Center for Cancer Research, National Cancer Institute, Frederick MD USA
  3. Universidade Federal de São Paulo-Escola Paulista de Medicina, Brazil
Publication Date:
Sponsoring Org.:
USDOE
OSTI Identifier:
1400594
Grant/Contract Number:
W-31-109-Eng-38
Resource Type:
Journal Article: Publisher's Accepted Manuscript
Journal Name:
Federation of European Biochemical Societies (FEBS) Journal
Additional Journal Information:
Journal Name: Federation of European Biochemical Societies (FEBS) Journal; Journal Volume: 284; Journal Issue: 3; Related Information: CHORUS Timestamp: 2017-10-20 15:01:32; Journal ID: ISSN 1742-464X
Publisher:
Wiley-Blackwell
Country of Publication:
United Kingdom
Language:
English

Citation Formats

Lubkowski, Jacek, Durbin, Sarah V., Silva, Mariana C. C., Farnsworth, David, Gildersleeve, Jeffrey C., Oliva, Maria Luiza V., and Wlodawer, Alexander. Structural analysis and unique molecular recognition properties of a Bauhinia forficata lectin that inhibits cancer cell growth. United Kingdom: N. p., 2017. Web. doi:10.1111/febs.13989.
Lubkowski, Jacek, Durbin, Sarah V., Silva, Mariana C. C., Farnsworth, David, Gildersleeve, Jeffrey C., Oliva, Maria Luiza V., & Wlodawer, Alexander. Structural analysis and unique molecular recognition properties of a Bauhinia forficata lectin that inhibits cancer cell growth. United Kingdom. doi:10.1111/febs.13989.
Lubkowski, Jacek, Durbin, Sarah V., Silva, Mariana C. C., Farnsworth, David, Gildersleeve, Jeffrey C., Oliva, Maria Luiza V., and Wlodawer, Alexander. Wed . "Structural analysis and unique molecular recognition properties of a Bauhinia forficata lectin that inhibits cancer cell growth". United Kingdom. doi:10.1111/febs.13989.
@article{osti_1400594,
title = {Structural analysis and unique molecular recognition properties of a Bauhinia forficata lectin that inhibits cancer cell growth},
author = {Lubkowski, Jacek and Durbin, Sarah V. and Silva, Mariana C. C. and Farnsworth, David and Gildersleeve, Jeffrey C. and Oliva, Maria Luiza V. and Wlodawer, Alexander},
abstractNote = {},
doi = {10.1111/febs.13989},
journal = {Federation of European Biochemical Societies (FEBS) Journal},
number = 3,
volume = 284,
place = {United Kingdom},
year = {Wed Feb 01 00:00:00 EST 2017},
month = {Wed Feb 01 00:00:00 EST 2017}
}

Journal Article:
Free Publicly Available Full Text
Publisher's Version of Record at 10.1111/febs.13989

Citation Metrics:
Cited by: 3works
Citation information provided by
Web of Science

Save / Share:
  • Patients with pancreatic cancer have little hope for cure because no effective therapies are available. Sansalvamide A is a cyclic depsipeptide produced by a marine fungus. We investigated the effect of a novel sansalvamide A analogue on growth, cell-cycle phases, and induction of apoptosis in human pancreatic cancer cells in vitro. The sansalvamide analogue caused marked time- and concentration-dependent inhibition of DNA synthesis and cell proliferation of two human pancreatic cancer cell lines (AsPC-1 and S2-013). The analogue induced G0/G1 phase cell-cycle arrest and morphological changes suggesting induction of apoptosis. Apoptosis was confirmed by annexin V binding. This novel sansalvamidemore » analogue inhibits growth of pancreatic cancer cells through G0/G1 arrest and induces apoptosis. Sansalvamide analogues may be valuable for the treatment of pancreatic cancer.« less
  • Fragile histidine triad (FHIT) gene is involved in the deletions at the 3p14.2 region in various cancers. We investigated the role of Fhit protein in cell growth by examining the signaling pathway affected by Fhit. We used 3 human colon cancer cell lines, SW480, DLD-1 and COLO201, in the study. SW480 cells, in which the expression of Fhit is completely absent, were transfected with pIRES1neo vector (SW/IRES cells), wild-type FHIT vector (SW/FHIT cells) or mt-FHIT (codon 96, His changed to Asn) vector (SW/mt-FHIT cells). The growth of SW/FHIT or SW/mt-FHIT cells was suppressed in comparison with that of parent ormore » SW/IRES cells. Especially, the growth of SW/FHIT cells was considerably suppressed. On the other hand, the silencing of FHIT by an siRNA for it in SW/FHIT or DLD-1 cells harboring Fhit demonstrated that the growth of FHIT siRNA-treated cells was significantly enhanced in comparison with that of the vector control or nonspecific siRNA control. Thus, we found that Fhit negatively contributed to cell growth in the colon cancer cell lines. Moreover, SW/FHIT cells exhibited a higher sensitivity to oxidative stress evoked by inhibitors of mitochondrial electron transport or proteasomes compared with any of the control transfectants. The base line amount of phospho-I{kappa}B-{alpha} (p-I{kappa}B-{alpha}) was reduced in SW/FHIT cells compared with that in the other transfectants. On the contrary, the FHIT siRNA-treated SW/FHIT and DLD-1 cells exhibited an elevated p-I{kappa}B-{alpha} level in an RNAi experiment on FHIT. Perturbation of nuclear factor (NF)-{kappa}B signaling was strongly suggested by the fact that the wild-type Fhit expressants of SW480 cells tended to be sensitive to sulfasarazine or parthenolide, which are inhibitors of NF-{kappa}B. The time course of the level of I{kappa}B kinase (IKK) complex (IKK{alpha}/{beta}, phospho-IKK{alpha}/{beta} and IKK{gamma}) after the treatment with TNF-{alpha} was similar between the transfectants. Although p-I{kappa}B-{alpha} and phospho-NF-{kappa}B p65 (p-NF-{kappa}B) in SW/FHIT cells responded to TNF-{alpha} as those in other transfectants, the increase in the levels of p-I{kappa}B-{alpha} and p-NF-{kappa}B after a 5-min treatment was less in SW/FHIT cells than in the other transfectants. These results altogether suggest that Fhit functions as an anti-oncoprotein by inhibiting the phosphorylation of I{kappa}B-{alpha} and thereby blocking NF-{kappa}B signaling.« less
  • In the search for a more potent bombesin antagonist, the authors found (D-Arg{sup 1},D-Phe{sup 5},D-Trp{sup 7,9},Leu{sup 11})substance P to be effective in mouse fibroblasts and to inhibit the growth of small cell lung cancer, a tumor that secretes bombesin-like peptides that may act as autocrine growth factors. In murine Swiss 3T3 cells, substance P proved to be a bombesin antagonist as judged by the following criteria: (i) inhibition of DNA synthesis induced by gastrin-releasing peptide and other bombesin-like peptides; (ii) inhibition of {sup 125}I-labeled gastrin-releasing peptide binding to the bombesin/gastrin-releasing peptide receptor; (iii) reduction in cross-linking of the M{sub r}more » 75,000-85,000 protein putatively a component of the bombesin/gastrin-releasing peptide receptor; (iv) blocking of early cellular events that precede mitogenesis-calcium mobilization and inhibition of epidermal growth factor binding. Substance P also inhibits mitogenesis induced by vasopressin but not that induced by a variety of other mitogens. Both antagonists reversibly inhibited the growth of small cell lung cancer in vitro in a concentration-dependent manner. Peptide antagonists could, therefore, have far-reaching therapeutic implications.« less
  • The HRPT2 (hereditary hyperparathyroidism type 2) tumor suppressor gene encodes a ubiquitously expressed 531 amino acid protein termed parafibromin. Inactivation of parafibromin predisposes one to the development of HPT-JT syndrome. To date, the role of parafibromin in tumorigenesis is largely unknown. Here, we report that parafibromin is a nuclear protein that possesses anti-proliferative properties. We show that overexpression of parafibromin inhibits colony formation and cellular proliferation, and induces cell cycle arrest in the G1 phase. Moreover, HPT-JT syndrome-derived mutations in HRPT2 behave in a dominant-negative manner by abolishing the ability of parafibromin to suppress cell proliferation. These findings suggest thatmore » parafibromin has a critical role in cell growth, and mutations in HRPT2 can directly inhibit this role.« less